Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Genome Therapeutics reaches milestone in antifungal alliance with Schering-Plough

Oct. 8, 1999

Microcide reports progress in efflux pump inhibitor programs at ICAAC

Oct. 7, 1999

HMR's 2-fluoro-ketolides warrant further exploration for Rx of respiratory tract infections

Oct. 7, 1999

BioCryst's cyclopentane influenza neuraminidase inhibitors profiled: competition for Tamiflu?

Oct. 6, 1999

Oligo Therapeutics designs completely new class of antimicrobial agents

Oct. 6, 1999

Over 10 abstracts related to nonfluoroquinolones presented by P&G at ICAAC

Oct. 6, 1999

New tricyclic acylides exhibit improved antibacterial activity

Oct. 6, 1999

Acylides as new third-generation macrolide antibiotics

Oct. 6, 1999

More good news for flu drug: oseltamivir featured in JAMA article

Oct. 6, 1999

P&U reports advance in the field of oxazolidinone antibacterials at ICAAC

Oct. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...